Cargando…
Digging deep into “dirty” drugs – modulation of the methylation machinery
DNA methylation and histone modification are epigenetic mechanisms that result in altered gene expression and cellular phenotype. The exact role of methylation in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) remains unclear. However, aberrations (e.g. loss-/gain-of-function or up...
Autores principales: | Pleyer, Lisa, Greil, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733942/ https://www.ncbi.nlm.nih.gov/pubmed/25566693 http://dx.doi.org/10.3109/03602532.2014.995379 |
Ejemplares similares
-
Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation
por: Greil, Richard, et al.
Publicado: (2017) -
Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
por: Leisch, Michael, et al.
Publicado: (2019) -
The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation
por: Wolff, Florian, et al.
Publicado: (2017) -
IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
por: Leisch, Michael, et al.
Publicado: (2020) -
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?
por: Pleyer, Lisa, et al.
Publicado: (2016)